SMAD3 and neoplasm: Subsequently, tumor formation experiments in nude mice revealed that NSUN5 KO significantly reduced SMAD3 and p‐SMAD3 levels in tumors, accompanied by an increase in E‐cadherin (an epithelial marker) and a decrease in vimentin (a mesenchymal marker) (Figure 3G).